Amy Peterson has joined CytomX Therapeutics (NASDAQ: CTMX) as executive vice president and chief development officer. Peterson was most recently chief medical officer of immune-oncology at BeiGene (NASDAQ: BGNE). Her experience also includes positions at Medivation and Roche subsidiary Genentech. South San Francisco-based CytomX is developing antibody drugs that treat cancer.
UNDERWRITERS AND PARTNERS
